Elanco Animal Health (ELAN) Cash & Equivalents Growth (1y) (2018 - 2026)

Elanco Animal Health (ELAN) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 38.67 Bn 34.93 Bn 1.97 Bn 120.45%
2 Zoetis 30.59 Bn 28.65 Bn 1.62 Bn 12.78%
3 RedHill Biopharma 26.22 Bn 26.22 Bn - -
4 United Therapeutics 23.80 Bn 21.65 Bn 648.10 Mn -32.64%
5 Curaleaf Holdings 23.70 Bn 23.70 Bn 157.29 Mn -
6 Viatris 18.69 Bn 16.89 Bn 1.16 Bn 138.97%
7 Neurocrine Biosciences 16.86 Bn 15.54 Bn 800.70 Mn 37.30%
8 Elanco Animal Health 11.99 Bn 11.57 Bn 785.00 Mn -12.11%
9 Dr Reddys Laboratories 11.65 Bn 11.51 Bn - -4.65%
10 Vireo Growth 10.64 Bn 10.52 Bn 59.30 Mn 42.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.11%
Dec 31, 2025 16.45%
Sep 30, 2025 3.06%
Jun 30, 2025 29.57%
Mar 31, 2025 41.16%
Dec 31, 2024 32.95%
Sep 30, 2024 32.79%
Jun 30, 2024 13.35%
Mar 31, 2024 8.49%
Dec 31, 2023 2.03%
Sep 30, 2023 -19.78%
Jun 30, 2023 -27.61%
Mar 31, 2023 -7.02%
Dec 31, 2022 -45.92%
Sep 30, 2022 1.55%
Jun 30, 2022 -12.59%
Mar 31, 2022 -33.59%
Dec 31, 2021 28.89%
Sep 30, 2021 -31.36%
Jun 30, 2021 -58.30%